Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease

Cognitive impairment is common in Parkinson's disease (PD), but often not improved by dopaminergic treatment. New treatment strategies targeting other neurotransmitter deficits are therefore of growing interest. Imaging the brain at rest (‘task-free') provides the opportunity to examine th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuropsychopharmacology
Autors principals: Borchert, Robin J, Rittman, Timothy, Passamonti, Luca, Ye, Zheng, Sami, Saber, Jones, Simon P, Nombela, Cristina, Vázquez Rodríguez, Patricia, Vatansever, Deniz, Rae, Charlotte L, Hughes, Laura E, Robbins, Trevor W, Rowe, James B
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4856878/
https://ncbi.nlm.nih.gov/pubmed/26837463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2016.18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars